Increase in serum IL-4 in response to venetoclax therapy in xenograft models of acute myeloid leukaemia

Despite significant progress in basic and preclinical research into acute myeloid leukaemia (AML), the five-year survival rate for patients with AML remains poor, highlighting the urgent need for new combination therapies. Over the past decade, increased attention has been focused on identifying sui...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	D. A. Bogdanova, V. V. Shindyapin, E. D. Kolosova, T. V. Pukhalskaya, N. A. Budkina, A. A. Shatilova, O. N. Demidov
Μορφή:	Artigo
Γλώσσα:	Russo
Έκδοση:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2024-07-01
Σειρά:	Медицинская иммунология
Θέματα:	xenograft model acute myeloid leukaemia nsg-sgm3 mice venetoclax il-4 apoptosis
Διαθέσιμο Online:	https://www.mimmun.ru/mimmun/article/view/3056
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!